메뉴 건너뛰기




Volumn 4, Issue 1, 2009, Pages 28-30

Apomorphine in the treatment of Parkinson's disease

Author keywords

Apomorphine; Continuous dopaminergic stimulation; Dyskinesias; Motor complications; Motor fluctuations; Parkinson's disease

Indexed keywords


EID: 84864498616     PISSN: 17583837     EISSN: 17583845     Source Type: Journal    
DOI: 10.17925/ENR.2009.04.01.28     Document Type: Article
Times cited : (3)

References (15)
  • 1
    • 0035353725 scopus 로고    scopus 로고
    • Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature
    • Ahlskog JE, Muenter MD, Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature, Mov Disord, 2001;16:448-58.
    • (2001) Mov Disord , vol.16 , pp. 448-458
    • Ahlskog, J.E.1    Muenter, M.D.2
  • 2
    • 22844442544 scopus 로고    scopus 로고
    • Identification of motor and nonmotor wearing-off in Parkinsońs disease: Comparison of a patient questionnaire versus a clinician assessment
    • Stacy M, Bowron A, Guttman M, et al. Identification of motor and nonmotor wearing-off in Parkinsońs disease: comparison of a patient questionnaire versus a clinician assessment, Mov Disord, 2005;20:726-33.
    • (2005) Mov Disord , vol.20 , pp. 726-733
    • Stacy, M.1    Bowron, A.2    Guttman, M.3
  • 3
    • 0031770529 scopus 로고    scopus 로고
    • Young-onset Parkinson's disease revisited: Clinical features, natural history, and mortality
    • Schrag A, Ben-Shlomo Y, Brown R, et al. Young-onset Parkinson's disease revisited: clinical features, natural history, and mortality, Mov Disord, 1998;13:885-94.
    • (1998) Mov Disord , vol.13 , pp. 885-894
    • Schrag, A.1    Ben-Shlomo, Y.2    Brown, R.3
  • 4
    • 33745605176 scopus 로고    scopus 로고
    • Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease
    • Olanow CW, Obeso JA, Stocchi F, Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease, Nat Clin Pract Neurol, 2006;2:382-92.
    • (2006) Nat Clin Pract Neurol , vol.2 , pp. 382-392
    • Olanow, C.W.1    Obeso, J.A.2    Stocchi, F.3
  • 5
    • 0035200697 scopus 로고    scopus 로고
    • Duodenal levodopa infusion in Parkinson's disease-long-term experience
    • Nilsson D, Nyholm D, Aquilonius SM, Duodenal levodopa infusion in Parkinson's disease-long-term experience, Acta Neurol Scand, 2001;104:343-8.
    • (2001) Acta Neurol Scand , vol.104 , pp. 343-348
    • Nilsson, D.1    Nyholm, D.2    Aquilonius, S.M.3
  • 6
    • 34249883912 scopus 로고    scopus 로고
    • Subcutaneous apomorphine in patients with advanced Parkinson's disease: A dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose
    • APO303 Study Investigators
    • Pahwa R, Koller WC, Trosch RM, Sherry JH, APO303 Study Investigators. Subcutaneous apomorphine in patients with advanced Parkinson's disease: a dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose, J Neurol Sci, 2007;258:137-43.
    • (2007) J Neurol Sci , vol.258 , pp. 137-143
    • Pahwa, R.1    Koller, W.C.2    Trosch, R.M.3    Sherry, J.H.4
  • 7
    • 20444374478 scopus 로고    scopus 로고
    • Apomorphine Injection Therapy for Parkinson's Disease
    • Odin P, Apomorphine Injection Therapy for Parkinson's Disease, Akt Neurol, 2005;32:50-55.
    • (2005) Akt Neurol , vol.32 , pp. 50-55
    • Odin, P.1
  • 9
    • 0031923068 scopus 로고    scopus 로고
    • Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease
    • Colzi A, Turner K, Lees AJ, Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease, J Neurol Neurosurg Psychiatry, 1998;64:573-6.
    • (1998) J Neurol Neurosurg Psychiatry , vol.64 , pp. 573-576
    • Colzi, A.1    Turner, K.2    Lees, A.J.3
  • 10
    • 52649108045 scopus 로고    scopus 로고
    • Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
    • García Ruiz PJ, Sesar Ignacio A, Ares Pensado B, et al. Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study, Mov Disord, 2008;23:1130-36.
    • (2008) Mov Disord , vol.23 , pp. 1130-1136
    • García Ruiz, P.J.1    Sesar Ignacio, A.2    Ares Pensado, B.3
  • 11
    • 20144366287 scopus 로고    scopus 로고
    • Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using singledose challenges
    • Katzenschlager R, Hughes A, Evans A, et al. Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using singledose challenges, Mov Disord, 2005;20:151-7.
    • (2005) Mov Disord , vol.20 , pp. 151-157
    • Katzenschlager, R.1    Hughes, A.2    Evans, A.3
  • 12
    • 0036869028 scopus 로고    scopus 로고
    • Apomorphine Monotherapy in the treatment of refractory motor complications of Parkinson's Disease-A long-term follow-up study of 64 patients
    • Manson AJ, Turner K, Lees AJ, Apomorphine Monotherapy in the treatment of refractory motor complications of Parkinson's Disease-A long-term follow-up study of 64 patients, Mov Disord, 2002;17:1235-41.
    • (2002) Mov Disord , vol.17 , pp. 1235-1241
    • Manson, A.J.1    Turner, K.2    Lees, A.J.3
  • 13
    • 12144278731 scopus 로고    scopus 로고
    • Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease
    • Alegret M, Valldeoriola F, Marti M, et al. Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease, Mov Disord, 2004;19:1463-9.
    • (2004) Mov Disord , vol.19 , pp. 1463-1469
    • Alegret, M.1    Valldeoriola, F.2    Marti, M.3
  • 14
    • 33645567169 scopus 로고    scopus 로고
    • Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus
    • De Gaspari D, Siri C, Landi A, et al. Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus, J Neurol Neurosurg Psychiatry, 2006;77:450-53.
    • (2006) J Neurol Neurosurg Psychiatry , vol.77 , pp. 450-453
    • De Gaspari, D.1    Siri, C.2    Landi, A.3
  • 15
    • 3042647039 scopus 로고    scopus 로고
    • Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: A follow-up of two years
    • Morgante L, Basile G, Epifanio A, et al. Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: a follow-up of two years, Arch Gerontol Geriatr Suppl, 2004; (9):291-6.
    • (2004) Arch Gerontol Geriatr Suppl , Issue.9 , pp. 291-296
    • Morgante, L.1    Basile, G.2    Epifanio, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.